Skip to main content
. Author manuscript; available in PMC: 2015 Jun 1.
Published in final edited form as: Mol Carcinog. 2013 Jan 28;53(6):471–479. doi: 10.1002/mc.22000

Figure 2.

Figure 2

Co-treatment with neutralizing anti-IL-12 antibody reverses both rIL-12 and silibinin-mediated protection against UVB-induced apoptosis in JB6 cells. (A–D) JB6 cells were irradiated with 50 mJ/cm2 UVB and treated with rIL-12 in presence or absence of anti-IL-12 antibody and/or 75 μM silibinin. Cells were harvested after 24 h, and percent apoptotic cells were calculated by Hoechst/PI staining. In each case, quantitative data shown are mean ± SE of triplicate samples of each treatment.